EPCORITAMAB-BYSP

EPCORITAMAB-BYSP was reported 1338 times

EPCORITAMAB-BYSP is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 HIGH GRADE B-CELL LYMPHOMA REFRACTORY 4 1.0000
1 DIFFUSE LARGE B-CELL LYMPHOMA REFRACTORY 235 0.2482
2 HAEMORRHAGIC GASTROENTERITIS 1 0.2000
3 B-CELL LYMPHOMA REFRACTORY 12 0.1348
4 EUSTACHIAN TUBE STENOSIS 1 0.1250
5 FOLLICULAR LYMPHOMA REFRACTORY 7 0.1077
6 ACUTE NECROTISING MYELITIS 1 0.1000
7 ATYPICAL LYMPHOCYTES INCREASED 2 0.0909
8 HIGH GRADE B-CELL LYMPHOMA RECURRENT 1 0.0909
9 KNUCKLE PADS 2 0.0870
10 LEUKAEMIC LYMPHOMA 3 0.0789
11 RETROPERITONEAL DISORDER 1 0.0435
12 NOCARDIA TEST POSITIVE 1 0.0385
13 ASCENDING FLACCID PARALYSIS 1 0.0370
14 VESSEL PUNCTURE SITE ERYTHEMA 1 0.0357
15 INCARCERATED INCISIONAL HERNIA 1 0.0357
16 GASTROINTESTINAL EXAMINATION ABNORMAL 1 0.0357
17 INTERLEUKIN-2 RECEPTOR INCREASED 6 0.0351
18 PRIMARY MEDIASTINAL LARGE B-CELL LYMPHOMA 4 0.0342
19 CAMPYLOBACTER BACTERAEMIA 1 0.0333
20 DIFFUSE LARGE B-CELL LYMPHOMA 251 0.0325
21 TUMOUR ASSOCIATED FEVER 13 0.0318
22 FUNGAL MYOSITIS 1 0.0286
23 SARS-COV-2 SEPSIS 1 0.0278
24 HIGH-GRADE B-CELL LYMPHOMA 5 0.0267
25 CITROBACTER SEPSIS 1 0.0250
26 FOLLICULAR LYMPHOMA STAGE III 1 0.0250
27 MALACOPLAKIA VESICAE 1 0.0250
28 CYTOKINE RELEASE SYNDROME 463 0.0231
29 TUMOUR PSEUDOPROGRESSION 22 0.0201
30 DOUBLE HIT LYMPHOMA 1 0.0200
31 SEPTIC CARDIOMYOPATHY 1 0.0200
32 TONSILLAR NEOPLASM 1 0.0196
33 FUNGATING WOUND 1 0.0192
34 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 108 0.0182
35 TUMOUR INFLAMMATION 2 0.0179
36 ORBITAL SWELLING 1 0.0172
37 CAROTID SINUS SYNDROME 1 0.0167
38 CYTOMEGALOVIRUS GASTRITIS 4 0.0158
39 MACROPHAGES INCREASED 1 0.0149
40 TUMOUR FLARE 10 0.0146
41 STENOTROPHOMONAS MALTOPHILIA PNEUMONIA 1 0.0145
42 ADENOVIRAL HAEMORRHAGIC CYSTITIS 3 0.0144
43 CORYNEBACTERIUM TEST POSITIVE 1 0.0141
44 CYTOMEGALOVIRUS TEST POSITIVE 25 0.0140
45 PNEUMORETROPERITONEUM 1 0.0133
46 STENOTROPHOMONAS BACTERAEMIA 1 0.0132
47 HISTIOCYTIC SARCOMA 1 0.0128
48 CYTOMEGALOVIRUS INFECTION REACTIVATION 56 0.0127
49 OEDEMA DUE TO HEPATIC DISEASE 1 0.0125
50 FOLLICULAR LYMPHOMA RECURRENT 1 0.0125
51 CYTOMEGALOVIRUS ENTEROCOLITIS 9 0.0117
52 SOCIOECONOMIC PRECARITY 2 0.0116
53 FOLLICULAR LYMPHOMA 10 0.0114
54 PORIOMANIA 2 0.0105
55 COMPUTERISED TOMOGRAM HEAD ABNORMAL 1 0.0101
56 BACILLUS TEST POSITIVE 1 0.0101
57 BLOOD BETA-D-GLUCAN INCREASED 3 0.0098
58 CYTOMEGALOVIRUS GASTROENTERITIS 2 0.0093
59 BACILLUS BACTERAEMIA 1 0.0092
60 DIFFUSE LARGE B-CELL LYMPHOMA RECURRENT 19 0.0086
61 STENOTROPHOMONAS TEST POSITIVE 1 0.0075
62 DISSEMINATED NOCARDIOSIS 1 0.0072
63 OCULAR LYMPHOMA 1 0.0071
64 ENCEPHALITIS CYTOMEGALOVIRUS 3 0.0068
65 RENAL CANCER RECURRENT 1 0.0068
66 DUODENAL OBSTRUCTION 2 0.0067
67 PERITONEAL HAEMATOMA 1 0.0067
68 HYPOGAMMAGLOBULINAEMIA 43 0.0065
69 TUMOUR INVASION 3 0.0062
70 VARICELLA VIRUS TEST POSITIVE 1 0.0059
71 SECONDARY IMMUNODEFICIENCY 7 0.0058
72 DISSEMINATED VARICELLA ZOSTER VIRUS INFECTION 2 0.0055
73 HERPES ZOSTER MENINGITIS 1 0.0055
74 ACINETOBACTER BACTERAEMIA 1 0.0053
75 PULMONARY HILUM MASS 1 0.0053
76 THROMBOTIC CEREBRAL INFARCTION 2 0.0053
77 INJECTION SITE ECZEMA 1 0.0052
78 CYTOMEGALOVIRUS VIRAEMIA 22 0.0049
79 IMMOBILISATION SYNDROME 1 0.0047
80 EMPHYSEMATOUS CYSTITIS 1 0.0047
81 HYPERFERRITINAEMIA 2 0.0046
82 GLOSSOPTOSIS 1 0.0046
83 GLUCOSE-6-PHOSPHATE DEHYDROGENASE DEFICIENCY 1 0.0043
84 BONE MARROW NECROSIS 1 0.0043
85 MENINGITIS FUNGAL 1 0.0043
86 AGNOSIA 1 0.0042
87 SPONTANEOUS BACTERIAL PERITONITIS 1 0.0041
88 BETA 2 MICROGLOBULIN INCREASED 1 0.0038
89 HERPES ZOSTER REACTIVATION 1 0.0038
90 HERPES ZOSTER DISSEMINATED 3 0.0037
91 CATHETER SITE THROMBOSIS 1 0.0036
92 ENTEROCOLITIS BACTERIAL 1 0.0036
93 BULBAR PALSY 1 0.0036
94 FIBRIN DEGRADATION PRODUCTS INCREASED 1 0.0034
95 PERIPHERAL T-CELL LYMPHOMA UNSPECIFIED 2 0.0034
96 ENTEROCOLITIS VIRAL 1 0.0033
97 ASPERGILLUS TEST POSITIVE 1 0.0032
98 BLOOD IMMUNOGLOBULIN G DECREASED 8 0.0032
99 ACTIVITIES OF DAILY LIVING DECREASED 2 0.0031
100 PHARYNGEAL OPERATION 1 0.0031
101 KLEBSIELLA TEST POSITIVE 2 0.0031
102 DIABETIC HYPERGLYCAEMIC COMA 1 0.0031
103 BLOOD LACTATE DEHYDROGENASE DECREASED 1 0.0030
104 PNEUMONIA ESCHERICHIA 1 0.0029
105 METASTATIC GASTRIC CANCER 1 0.0029
106 FUNGAL TEST POSITIVE 1 0.0028
107 CYTOMEGALOVIRUS ENTERITIS 1 0.0028
108 EYE SYMPTOM 1 0.0028
109 LYMPHOMA TRANSFORMATION 1 0.0028
110 DYSLALIA 2 0.0028
111 APALLIC SYNDROME 2 0.0028
112 PATIENT ELOPEMENT 1 0.0027
113 EAR OPERATION 1 0.0027
114 OTITIS MEDIA ACUTE 2 0.0027
115 HUMORAL IMMUNE DEFECT 1 0.0027
116 ACETABULUM FRACTURE 1 0.0027
117 CONJUNCTIVAL DISORDER 1 0.0026
118 T-CELL LYMPHOMA 3 0.0026
119 BONE MARROW INFILTRATION 1 0.0026
120 HYPOALBUMINAEMIA 20 0.0026
121 PULMONARY ARTERY STENOSIS 1 0.0026
122 PNEUMONIA MYCOPLASMAL 2 0.0025
123 VIRAL PHARYNGITIS 1 0.0025
124 ENCEPHALITIS VIRAL 3 0.0025
125 PSEUDOMONAS TEST POSITIVE 2 0.0024
126 METASTASES TO THE MEDIASTINUM 1 0.0024
127 PSEUDOMONAL BACTERAEMIA 2 0.0023
128 ENTEROVIRUS INFECTION 2 0.0023
129 TUMOUR PAIN 3 0.0023
130 HERPES OPHTHALMIC 3 0.0023
131 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 17 0.0023
132 FACIAL NERVE DISORDER 1 0.0023
133 LYMPH GLAND INFECTION 1 0.0022
134 CYTOMEGALOVIRUS INFECTION 36 0.0022
135 CENTRAL NERVOUS SYSTEM HAEMORRHAGE 1 0.0021
136 SMALL INTESTINAL PERFORATION 4 0.0021
137 BLOOD PHOSPHORUS ABNORMAL 1 0.0021
138 PNEUMONIA HAEMOPHILUS 1 0.0021
139 PNEUMONIA CYTOMEGALOVIRAL 4 0.0021
140 CARDIAC VALVE VEGETATION 1 0.0021
141 CYTOMEGALOVIRUS CHORIORETINITIS 4 0.0020
142 ENCEPHALITIS HERPES 1 0.0020
143 HYPOFIBRINOGENAEMIA 2 0.0020
144 METASTASES TO BONE MARROW 1 0.0020
145 CSF TEST ABNORMAL 1 0.0020
146 INTENTIONAL MEDICAL DEVICE REMOVAL BY PATIENT 2 0.0020
147 LOWER RESPIRATORY TRACT INFECTION VIRAL 1 0.0020
148 MARASMUS 3 0.0020
149 B-CELL LYMPHOMA RECURRENT 1 0.0018
150 BRONCHOSTENOSIS 1 0.0018
151 INTERLEUKIN LEVEL INCREASED 1 0.0018
152 ADRENAL HAEMORRHAGE 1 0.0018
153 BLOOD FIBRINOGEN DECREASED 2 0.0018
154 PNEUMONIA BACTERIAL 16 0.0017
155 BLOOD LACTATE DEHYDROGENASE INCREASED 27 0.0017
156 MALIGNANT PERITONEAL NEOPLASM 1 0.0017
157 SUPERIOR VENA CAVA SYNDROME 1 0.0017
158 PROSTATE CANCER RECURRENT 1 0.0016
159 PSOAS ABSCESS 1 0.0016
160 ILEAL PERFORATION 1 0.0015
161 URETHRAL STENOSIS 1 0.0015
162 NASAL OPERATION 1 0.0015
163 CYTOKINE STORM 1 0.0015
164 POSITRON EMISSION TOMOGRAM ABNORMAL 1 0.0014
165 NEUTROPHIL COUNT DECREASED 58 0.0014
166 VIRAL HAEMORRHAGIC CYSTITIS 1 0.0014
167 GASTROINTESTINAL SCARRING 1 0.0014
168 PANCREATIC ENZYMES INCREASED 2 0.0014
169 STEROID DIABETES 2 0.0013
170 HEART SOUNDS ABNORMAL 1 0.0013
171 CHOLANGITIS ACUTE 1 0.0013
172 ENTEROVESICAL FISTULA 1 0.0013
173 PALLIATIVE CARE 2 0.0013
174 MALIGNANT ASCITES 1 0.0013
175 PNEUMONIA PSEUDOMONAL 2 0.0013
176 METAPNEUMOVIRUS INFECTION 1 0.0013
177 ESCHERICHIA BACTERAEMIA 3 0.0013
178 TUMOUR LYSIS SYNDROME 11 0.0012
179 URETERIC STENOSIS 1 0.0012
180 CSF PROTEIN INCREASED 1 0.0012
181 SYSTEMIC CANDIDA 3 0.0012
182 MEAN PLATELET VOLUME DECREASED 1 0.0012
183 COVID-19 PNEUMONIA 14 0.0012
184 B-CELL LYMPHOMA 4 0.0012
185 ENTERITIS INFECTIOUS 2 0.0012
186 THALAMUS HAEMORRHAGE 1 0.0011
187 ENTEROCUTANEOUS FISTULA 1 0.0011
188 NUCHAL RIGIDITY 1 0.0011
189 PERFORMANCE STATUS DECREASED 5 0.0011
190 BRAIN STEM HAEMORRHAGE 1 0.0011
191 HUMAN HERPESVIRUS 6 INFECTION 2 0.0011
192 KLEBSIELLA BACTERAEMIA 1 0.0011
193 FOREIGN BODY IN EYE 1 0.0010
194 MALIGNANT NEOPLASM PROGRESSION 104 0.0010
195 PNEUMONIA FUNGAL 4 0.0010
196 PYURIA 1 0.0010
197 BLADDER CANCER RECURRENT 1 0.0010
198 SUDDEN HEARING LOSS 2 0.0010
199 INTESTINAL PERFORATION 11 0.0010
200 STEROID WITHDRAWAL SYNDROME 1 0.0010
201 NEUTROPENIC COLITIS 2 0.0010
202 INTENTIONAL UNDERDOSE 7 0.0010
203 TUMOUR NECROSIS 1 0.0009
204 ENTEROCOCCAL BACTERAEMIA 1 0.0009
205 BACTERAEMIA 11 0.0009
206 STAPHYLOCOCCAL BACTERAEMIA 4 0.0009
207 KLEBSIELLA SEPSIS 1 0.0009
208 CYTOGENETIC ABNORMALITY 1 0.0009
209 SARCOMA 1 0.0009
210 METASTASES TO MENINGES 2 0.0009
211 SYSTEMIC MYCOSIS 1 0.0009
212 PROCALCITONIN INCREASED 1 0.0009
213 HAEMATOMA MUSCLE 1 0.0008
214 UPPER RESPIRATORY TRACT INFLAMMATION 1 0.0008
215 CHRONIC RESPIRATORY FAILURE 1 0.0008
216 HAEMATOLOGICAL INFECTION 2 0.0008
217 EASTERN COOPERATIVE ONCOLOGY GROUP PERFORMANCE STATUS WORSENED 1 0.0008
218 PROTEIN TOTAL DECREASED 3 0.0008
219 PNEUMOCYSTIS JIROVECII PNEUMONIA 8 0.0008
220 METASTASES TO PERITONEUM 2 0.0008
221 CANCER PAIN 2 0.0008
222 HEPATOSPLENOMEGALY 2 0.0008
223 PHYSICAL DECONDITIONING 2 0.0008
224 RHINOVIRUS INFECTION 3 0.0008
225 ASPERGILLUS INFECTION 5 0.0008
226 LUNG OPACITY 2 0.0008
227 SERUM FERRITIN INCREASED 4 0.0008
228 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 2 0.0008
229 GASTRIC PERFORATION 2 0.0007
230 URETERIC OBSTRUCTION 1 0.0007
231 MENINGITIS VIRAL 1 0.0007
232 SPINAL STENOSIS 3 0.0007
233 LYMPHOMA 11 0.0007
234 ACUTE GRAFT VERSUS HOST DISEASE IN INTESTINE 1 0.0007
235 PNEUMATOSIS INTESTINALIS 2 0.0007
236 POST HERPETIC NEURALGIA 1 0.0007
237 RED BLOOD CELL COUNT ABNORMAL 1 0.0007
238 ENTEROCOLITIS HAEMORRHAGIC 1 0.0007
239 PNEUMONIA PNEUMOCOCCAL 1 0.0007
240 APRAXIA 1 0.0007
241 CHOLANGIOCARCINOMA 1 0.0007
242 DELIRIUM 23 0.0007
243 SECONDARY ADRENOCORTICAL INSUFFICIENCY 1 0.0007
244 INFECTIOUS PLEURAL EFFUSION 1 0.0007
245 INTERCEPTED PRODUCT PREPARATION ERROR 8 0.0006
246 LYMPHOPENIA 9 0.0006
247 FUNGAEMIA 1 0.0006
248 HEPATITIS B REACTIVATION 2 0.0006
249 BACTERIAL SEPSIS 2 0.0006
250 DYSGRAPHIA 4 0.0006
251 CORONAVIRUS INFECTION 4 0.0006
252 VEIN RUPTURE 1 0.0006
253 MALIGNANT PLEURAL EFFUSION 1 0.0006
254 SEIZURE LIKE PHENOMENA 1 0.0006
255 GAZE PALSY 1 0.0006
256 LAZINESS 1 0.0006
257 FEMORAL NECK FRACTURE 3 0.0006
258 AUTOIMMUNE HAEMOLYTIC ANAEMIA 2 0.0006
259 BLOOD CHLORIDE INCREASED 1 0.0006
260 SERUM FERRITIN DECREASED 1 0.0006
261 TREATMENT DELAYED 1 0.0006
262 EXTREMITY NECROSIS 1 0.0006
263 MENINGITIS CRYPTOCOCCAL 1 0.0006
264 PSEUDOMONAL SEPSIS 1 0.0006
265 ERYTHEMA OF EYELID 3 0.0006
266 ALTERED STATE OF CONSCIOUSNESS 12 0.0006
267 FULL BLOOD COUNT DECREASED 11 0.0005
268 PNEUMONIA KLEBSIELLA 1 0.0005
269 METASTASES TO CENTRAL NERVOUS SYSTEM 7 0.0005
270 OPPORTUNISTIC INFECTION 1 0.0005
271 PUPILLARY REFLEX IMPAIRED 1 0.0005
272 GRANULOCYTE COUNT DECREASED 1 0.0005
273 LYMPH NODE PAIN 1 0.0005
274 CARDIAC DYSFUNCTION 2 0.0005
275 AURA 1 0.0005
276 INTERVERTEBRAL DISCITIS 1 0.0005
277 LYMPHADENOPATHY MEDIASTINAL 1 0.0005
278 HEPATIC MASS 1 0.0005
279 ABDOMINAL WALL HAEMATOMA 1 0.0005
280 MULTI-ORGAN DISORDER 1 0.0005
281 ANORECTAL DISORDER 1 0.0005
282 DEVICE RELATED SEPSIS 1 0.0005
283 C-REACTIVE PROTEIN INCREASED 18 0.0005
284 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 4 0.0005
285 HYPOXIA 17 0.0005
286 VARICELLA ZOSTER VIRUS INFECTION 1 0.0005
287 GASTROINTESTINAL PERFORATION 2 0.0005
288 DEPRESSED LEVEL OF CONSCIOUSNESS 19 0.0005
289 GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT 1 0.0005
290 MYOPATHY 4 0.0005
291 OESOPHAGEAL VARICES HAEMORRHAGE 1 0.0005
292 IMMOBILE 2 0.0005
293 NEUROTOXICITY 8 0.0005
294 GRAFT VERSUS HOST DISEASE IN SKIN 1 0.0005
295 MENINGITIS 3 0.0004
296 ADENOCARCINOMA 1 0.0004
297 DISTRIBUTIVE SHOCK 1 0.0004
298 LOCALISED OEDEMA 2 0.0004
299 HYPERTRANSAMINASAEMIA 3 0.0004
300 PYREXIA 148 0.0004
301 DISSEMINATED INTRAVASCULAR COAGULATION 6 0.0004
302 PULMONARY INFARCTION 1 0.0004
303 PLATELET COUNT DECREASED 45 0.0004
304 URINARY TRACT OBSTRUCTION 1 0.0004
305 DIABETES INSIPIDUS 1 0.0004
306 MYELODYSPLASTIC SYNDROME 6 0.0004
307 PRODUCT PACKAGING CONFUSION 1 0.0004
308 BRONCHITIS CHRONIC 1 0.0004
309 DECREASED IMMUNE RESPONSIVENESS 4 0.0004
310 STAPHYLOCOCCAL SEPSIS 2 0.0004
311 HYDRONEPHROSIS 3 0.0004
312 BLOOD CHLORIDE DECREASED 1 0.0004
313 ACTINIC KERATOSIS 1 0.0004
314 MUCORMYCOSIS 1 0.0004
315 BLOOD POTASSIUM ABNORMAL 1 0.0004
316 ASCITES 11 0.0004
317 SHOCK HAEMORRHAGIC 3 0.0004
318 INTESTINAL ISCHAEMIA 2 0.0004
319 GASTRIC ULCER HAEMORRHAGE 2 0.0004
320 SECOND PRIMARY MALIGNANCY 3 0.0004
321 PSYCHOMOTOR RETARDATION 1 0.0004
322 NECK MASS 1 0.0004
323 TUMOUR HAEMORRHAGE 1 0.0004
324 NEUROLOGICAL SYMPTOM 2 0.0003
325 ENTEROCOLITIS 2 0.0003
326 PYELONEPHRITIS 3 0.0003
327 ADENOVIRUS INFECTION 1 0.0003
328 LYMPHOPROLIFERATIVE DISORDER 1 0.0003
329 ATYPICAL PNEUMONIA 1 0.0003
330 BLOOD CULTURE POSITIVE 1 0.0003
331 LUNG ADENOCARCINOMA 1 0.0003
332 HYPERCAPNIA 1 0.0003
333 PLATELET COUNT ABNORMAL 2 0.0003
334 BRAIN NATRIURETIC PEPTIDE INCREASED 1 0.0003
335 EPSTEIN-BARR VIRUS INFECTION 2 0.0003
336 RESPIRATORY RATE DECREASED 1 0.0003
337 NON-CARDIAC CHEST PAIN 1 0.0003
338 VENTRICULAR HYPOKINESIA 1 0.0003
339 LYMPHADENOPATHY 11 0.0003
340 COVID-19 54 0.0003
341 POSTURE ABNORMAL 1 0.0003
342 HYPOVENTILATION 1 0.0003
343 INJECTION SITE INFECTION 1 0.0003
344 SARS-COV-2 TEST POSITIVE 4 0.0003
345 OTITIS MEDIA 1 0.0003
346 ATRIOVENTRICULAR BLOCK COMPLETE 2 0.0003
347 POTENTIATING DRUG INTERACTION 1 0.0003
348 JOINT EFFUSION 2 0.0003
349 BLOOD CREATININE ABNORMAL 1 0.0003
350 DERMATITIS EXFOLIATIVE GENERALISED 1 0.0003
351 TYPE I HYPERSENSITIVITY 1 0.0003
352 DEPRESSIVE SYMPTOM 1 0.0003
353 NECROTISING FASCIITIS 1 0.0003
354 HAEMORRHAGIC DIATHESIS 1 0.0003
355 INTERCEPTED PRODUCT STORAGE ERROR 1 0.0003
356 MYELOSUPPRESSION 10 0.0003
357 SPONDYLITIS 1 0.0003
358 VENTRICULAR ARRHYTHMIA 1 0.0003
359 AMYLASE INCREASED 1 0.0003
360 LEUKOENCEPHALOPATHY 1 0.0003
361 RETINOPATHY 1 0.0003
362 BLOOD CALCIUM DECREASED 3 0.0003
363 ADVERSE EVENT 24 0.0003
364 APNOEA 2 0.0003
365 FEBRILE NEUTROPENIA 17 0.0003
366 SPLENOMEGALY 3 0.0003
367 ORAL INFECTION 1 0.0003
368 SEPTIC SHOCK 11 0.0003
369 CHOLECYSTITIS 3 0.0003
370 SEPSIS 28 0.0003
371 CEREBRAL ATROPHY 1 0.0003
372 ATRIAL FLUTTER 2 0.0003
373 PANCYTOPENIA 14 0.0003
374 LIVER DISORDER 11 0.0002
375 ADRENAL INSUFFICIENCY 3 0.0002
376 PLEURAL EFFUSION 15 0.0002
377 PERIPHERAL VENOUS DISEASE 1 0.0002
378 ASPARTATE AMINOTRANSFERASE INCREASED 13 0.0002
379 ALANINE AMINOTRANSFERASE INCREASED 15 0.0002
380 DEMYELINATION 1 0.0002
381 HYPERAESTHESIA 2 0.0002
382 HYPERURICAEMIA 1 0.0002
383 HYPERCALCAEMIA 3 0.0002
384 ABSCESS LIMB 1 0.0002
385 PULMONARY TUBERCULOSIS 1 0.0002
386 PSEUDOMONAS INFECTION 2 0.0002
387 HEPATIC LESION 1 0.0002
388 OCULAR ICTERUS 1 0.0002
389 MONOPLEGIA 1 0.0002
390 URINE ABNORMALITY 1 0.0002
391 ACUTE GRAFT VERSUS HOST DISEASE 1 0.0002
392 DISEASE COMPLICATION 1 0.0002
393 ISCHAEMIA 1 0.0002
394 THROMBOCYTOPENIA 24 0.0002
395 BACTERIAL INFECTION 4 0.0002
396 DEFORMITY 2 0.0002
397 NEUTROPENIA 29 0.0002
398 VIRAL UPPER RESPIRATORY TRACT INFECTION 1 0.0002
399 ENTEROCOCCAL INFECTION 1 0.0002
400 GUILLAIN-BARRE SYNDROME 1 0.0002
401 INJECTION SITE REACTION 14 0.0002
402 VENOOCCLUSIVE LIVER DISEASE 1 0.0002
403 INFLAMMATORY MARKER INCREASED 1 0.0002
404 NEOPLASM PROGRESSION 7 0.0002
405 PNEUMONIA ASPIRATION 5 0.0002
406 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 1 0.0002
407 PATHOLOGICAL FRACTURE 1 0.0002
408 MOTOR DYSFUNCTION 2 0.0002
409 INJECTION SITE RASH 6 0.0002
410 HYPONATRAEMIA 11 0.0002
411 ENDOCARDITIS 1 0.0002
412 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 2 0.0002
413 PRODUCT TEMPERATURE EXCURSION ISSUE 1 0.0002
414 CEREBRAL ISCHAEMIA 1 0.0002
415 HYPERBILIRUBINAEMIA 2 0.0002
416 FOOD CRAVING 1 0.0002
417 CLOSTRIDIUM DIFFICILE COLITIS 2 0.0002
418 COMPRESSION FRACTURE 1 0.0002
419 ANAL ABSCESS 1 0.0002
420 GAMMA-GLUTAMYLTRANSFERASE INCREASED 4 0.0002
421 OBSTRUCTIVE AIRWAYS DISORDER 2 0.0002
422 EYE INFECTION 2 0.0002
423 MULTIPLE ORGAN DYSFUNCTION SYNDROME 5 0.0002
424 PERONEAL NERVE PALSY 1 0.0002
425 WHITE BLOOD CELL COUNT DECREASED 19 0.0002
426 HERPES VIRUS INFECTION 1 0.0002
427 METASTASES TO LUNG 2 0.0002
428 ELECTROLYTE IMBALANCE 2 0.0002
429 LYMPHOCYTE COUNT DECREASED 3 0.0002
430 ACUTE RESPIRATORY DISTRESS SYNDROME 3 0.0002
431 HEPATIC FAILURE 5 0.0002
432 INFECTION 24 0.0002
433 CEREBRAL INFARCTION 4 0.0002
434 LARYNGEAL OEDEMA 1 0.0002
435 AGRANULOCYTOSIS 3 0.0002
436 CHOLANGITIS 1 0.0002
437 NERVOUS SYSTEM DISORDER 5 0.0002
438 HEPATIC CIRRHOSIS 3 0.0002
439 FRACTURE 3 0.0002
440 WHITE BLOOD CELL COUNT ABNORMAL 1 0.0002
441 HAEMOGLOBIN ABNORMAL 1 0.0002
442 INJECTION SITE INDURATION 2 0.0002
443 ATRIAL FIBRILLATION 15 0.0002
444 PRODUCT PREPARATION ISSUE 1 0.0002
445 IMMUNE SYSTEM DISORDER 2 0.0002
446 CARDIAC FAILURE ACUTE 1 0.0001
447 COLITIS ISCHAEMIC 1 0.0001
448 BLOOD BILIRUBIN INCREASED 4 0.0001
449 INTERSTITIAL LUNG DISEASE 7 0.0001
450 MENTAL STATUS CHANGES 4 0.0001
451 LARGE INTESTINE PERFORATION 1 0.0001
452 HOSPITALISATION 22 0.0001
453 RENAL IMPAIRMENT 12 0.0001
454 DEFAECATION URGENCY 1 0.0001
455 OXYGEN SATURATION DECREASED 8 0.0001
456 PULMONARY TOXICITY 1 0.0001
457 THERMAL BURN 1 0.0001
458 SINUS TACHYCARDIA 2 0.0001
459 METASTASIS 1 0.0001
460 LIVER FUNCTION TEST INCREASED 3 0.0001
461 RASH PUSTULAR 1 0.0001
462 CARDIAC FAILURE 11 0.0001
463 ANAEMIA 26 0.0001
464 MELAENA 3 0.0001
465 LABORATORY TEST ABNORMAL 4 0.0001
466 BLOOD PRESSURE DECREASED 9 0.0001
467 CEREBRAL DISORDER 1 0.0001
468 HEPATOCELLULAR CARCINOMA 1 0.0001
469 ACIDOSIS 1 0.0001
470 LIPASE INCREASED 1 0.0001
471 HYPOKALAEMIA 6 0.0001
472 DEVICE RELATED INFECTION 2 0.0001
473 GENERAL PHYSICAL HEALTH DETERIORATION 15 0.0001
474 ATRIOVENTRICULAR BLOCK 1 0.0001
475 OEDEMA 7 0.0001
476 BRONCHOPULMONARY ASPERGILLOSIS 1 0.0001
477 GASTROINTESTINAL INFLAMMATION 1 0.0001
478 FURUNCLE 1 0.0001
479 DISORIENTATION 5 0.0001
480 PNEUMOTHORAX 2 0.0001
481 BLOOD ALBUMIN DECREASED 1 0.0001
482 ABSCESS 2 0.0001
483 BLOOD DISORDER 1 0.0001
484 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 22 0.0001
485 VENTRICULAR TACHYCARDIA 2 0.0001
486 PNEUMONIA 39 0.0001
487 HEMIPLEGIA 1 0.0001
488 COAGULOPATHY 2 0.0001
489 BLOOD UREA INCREASED 2 0.0001
490 FACIAL PARALYSIS 1 0.0001
491 INFLAMMATION 6 0.0001
492 RESPIRATORY TRACT INFECTION 3 0.0001
493 HYPERKALAEMIA 4 0.0001
494 BLOOD CALCIUM INCREASED 1 0.0001
495 IMMUNOSUPPRESSION 1 0.0001
496 FACIAL PAIN 1 0.0001
497 GASTROINTESTINAL INFECTION 1 0.0001
498 MYOSITIS 1 0.0001
499 PNEUMONITIS 3 0.0001
500 RETINAL DETACHMENT 1 0.0001
501 DIVERTICULITIS 3 0.0001
502 ERYTHEMA MULTIFORME 1 0.0001
503 BLOOD CREATININE INCREASED 7 0.0001
504 HEPATIC FUNCTION ABNORMAL 4 0.0001
505 FLANK PAIN 1 0.0001
506 SPUTUM DISCOLOURED 1 0.0001
507 HAEMATOTOXICITY 1 0.0001
508 PRODUCTIVE COUGH 5 0.0001
509 HYPOTENSION 21 0.0001
510 SUPRAVENTRICULAR TACHYCARDIA 1 0.0001
511 HERPES ZOSTER 6 0.0001
512 WHITE BLOOD CELL COUNT INCREASED 4 0.0001
513 HEPATOMEGALY 1 0.0001
514 HAEMATOCRIT DECREASED 2 0.0001
515 BLADDER DISORDER 1 0.0001
516 RESPIRATORY DISORDER 3 0.0001
517 TOOTH ABSCESS 1 0.0001
518 PERITONITIS 2 0.0001
519 PETECHIAE 1 0.0001
520 CARDIO-RESPIRATORY ARREST 4 0.0001
521 JOINT DISLOCATION 1 0.0001
522 SUDDEN DEATH 1 0.0001
523 HYPOTHYROIDISM 3 0.0001
524 INJECTION SITE PRURITUS 6 0.0001
525 THERAPY NON-RESPONDER 4 0.0001
526 MITRAL VALVE INCOMPETENCE 1 0.0001
527 NEOPLASM 1 0.0001
528 SHOCK 2 0.0001
529 PERICARDIAL EFFUSION 2 0.0001
530 ABDOMINAL PAIN 20 0.0001
531 COGNITIVE DISORDER 4 0.0001
532 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 6 0.0001
533 ATAXIA 1 0.0001
534 THERAPY INTERRUPTED 6 0.0001
535 GASTROINTESTINAL HAEMORRHAGE 7 0.0001
536 HYPERGLYCAEMIA 3 0.0001
537 RESPIRATORY FAILURE 6 0.0001
538 NEURALGIA 2 0.0001
539 CYTOPENIA 1 0.0001
540 INJECTION SITE URTICARIA 2 0.0001
541 GLOMERULAR FILTRATION RATE DECREASED 1 0.0001
542 TENDON RUPTURE 1 0.0001
543 GENERALISED OEDEMA 1 0.0001
544 INJECTION SITE ERYTHEMA 10 0.0001
545 ILEUS 1 0.0001
546 AGEUSIA 2 0.0001
547 BRAIN OEDEMA 1 0.0001
548 COLITIS 3 0.0001
549 HEPATITIS 2 0.0001
550 DEAFNESS 2 0.0001
551 BEDRIDDEN 1 0.0001
552 ORAL CANDIDIASIS 1 0.0001
553 PULMONARY CONGESTION 1 0.0001
554 ABNORMAL BEHAVIOUR 3 0.0001
555 ADVERSE REACTION 1 0.0001
556 UVEITIS 1 0.0001
557 IMPAIRED GASTRIC EMPTYING 1 0.0001
558 PERIPHERAL COLDNESS 1 0.0001
559 HAEMATOCHEZIA 4 0.0001
560 HYPOMAGNESAEMIA 1 0.0001
561 DEMENTIA 2 0.0001
562 PRODUCT DOSE OMISSION IN ERROR 2 0.0001
563 RED BLOOD CELL COUNT DECREASED 2 0.0001
564 SUBDURAL HAEMATOMA 1 0.0001
565 MOBILITY DECREASED 5 0.0001
566 HYPOKINESIA 1 0.0001
567 DYSSTASIA 2 0.0001
568 DISEASE PROGRESSION 8 0.0001
569 URINARY INCONTINENCE 2 0.0001
570 THERAPEUTIC PRODUCT EFFECT DECREASED 3 0.0001
571 HAEMORRHAGE INTRACRANIAL 1 0.0001
572 NO ADVERSE EVENT 12 0.0001
573 APHASIA 2 0.0001
574 EPILEPSY 2 0.0001
575 DECREASED APPETITE 15 0.0001
576 FEMUR FRACTURE 2 0.0001
577 RENAL DISORDER 3 0.0001
578 DELUSION 1 0.0001
579 EJECTION FRACTION DECREASED 1 0.0001
580 ACUTE MYELOID LEUKAEMIA 1 0.0001
581 CYSTITIS 2 0.0001
582 SENSORY DISTURBANCE 1 0.0001
583 LACTIC ACIDOSIS 2 0.0001
584 BLOOD POTASSIUM INCREASED 1 0.0001
585 METASTASES TO BONE 1 0.0001
586 STAPHYLOCOCCAL INFECTION 2 0.0001
587 VISUAL ACUITY REDUCED 2 0.0001
588 CHILLS 7 0.0001
589 CONSTIPATION 13 0.0001
590 FACE OEDEMA 1 0.0001
591 CANDIDA INFECTION 1 0.0001
592 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 1 0.0001
593 HAEMOGLOBIN DECREASED 6 0.0001
594 ORTHOSTATIC HYPOTENSION 1 0.0001
595 EOSINOPHILIA 1 0.0001
596 MALAISE 25 0.0001
597 METASTASES TO LIVER 1 0.0001
598 DRUG ERUPTION 1 0.0001
599 TACHYCARDIA 5 0.0001
600 GASTROENTERITIS VIRAL 1 0.0001
601 LEUKOCYTOSIS 1 0.0001
602 PELVIC PAIN 1 0.0001
603 RESTLESS LEGS SYNDROME 1 0.0001
604 CONJUNCTIVITIS 1 0.0001
605 INFLUENZA 6 0.0001
606 HEPATIC STEATOSIS 1 0.0001
607 SWELLING 5 0.0001
608 DYSARTHRIA 2 0.0001
609 INTESTINAL OBSTRUCTION 2 0.0001
610 BLOOD SODIUM DECREASED 1 0.0001
611 MUSCULAR WEAKNESS 6 0.0001
612 FOOT FRACTURE 1 0.0001
613 NEUROPATHY PERIPHERAL 5 0.0001
614 FEELING JITTERY 1 0.0001
615 INJECTION SITE SWELLING 4 0.0001
616 SEIZURE 6 0.0001
617 BACK PAIN 12 0.0001
618 DYSPHONIA 3 0.0001
619 SINUS DISORDER 1 0.0001
620 PRESCRIBED UNDERDOSE 1 0.0001
621 SPINAL FRACTURE 1 0.0000
622 THROMBOSIS 4 0.0000
623 FEEDING DISORDER 1 0.0000
624 OEDEMA PERIPHERAL 6 0.0000
625 BODY TEMPERATURE INCREASED 1 0.0000
626 PRODUCT PREPARATION ERROR 1 0.0000
627 INJECTION SITE WARMTH 1 0.0000
628 RASH 21 0.0000
629 POLLAKIURIA 2 0.0000
630 ABDOMINAL DISTENSION 5 0.0000
631 DERMATITIS 1 0.0000
632 FAECES DISCOLOURED 1 0.0000
633 CLOSTRIDIUM DIFFICILE INFECTION 1 0.0000
634 ACUTE KIDNEY INJURY 7 0.0000
635 INFUSION RELATED REACTION 3 0.0000
636 TRANSAMINASES INCREASED 1 0.0000
637 HEPATOTOXICITY 1 0.0000
638 PANCREATITIS ACUTE 1 0.0000
639 CHROMATURIA 1 0.0000
640 PRODUCT DOSE OMISSION ISSUE 13 0.0000
641 DEATH 38 0.0000
642 MUSCLE TWITCHING 1 0.0000
643 UPPER RESPIRATORY TRACT INFECTION 2 0.0000
644 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 1 0.0000
645 CARDIAC DISORDER 4 0.0000
646 ARRHYTHMIA 2 0.0000
647 DYSPHAGIA 4 0.0000
648 TOXICITY TO VARIOUS AGENTS 7 0.0000
649 HYPOGLYCAEMIA 2 0.0000
650 URINARY TRACT INFECTION 7 0.0000
651 OSTEONECROSIS OF JAW 1 0.0000
652 BLOOD ALKALINE PHOSPHATASE INCREASED 1 0.0000
653 HAEMATEMESIS 1 0.0000
654 CARDIOVASCULAR DISORDER 1 0.0000
655 HYPOPHAGIA 1 0.0000
656 CHEST DISCOMFORT 4 0.0000
657 UNRESPONSIVE TO STIMULI 1 0.0000
658 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 2 0.0000
659 PANCREATITIS 2 0.0000
660 DEPRESSED MOOD 2 0.0000
661 RENAL FAILURE 5 0.0000
662 EAR INFECTION 1 0.0000
663 JAUNDICE 1 0.0000
664 RASH PRURITIC 2 0.0000
665 SKIN LESION 1 0.0000
666 CARDIAC ARREST 3 0.0000
667 FALL 12 0.0000
668 FEELING COLD 1 0.0000
669 HAEMOPTYSIS 1 0.0000
670 WOUND 1 0.0000
671 COUGH 10 0.0000
672 EYE PAIN 2 0.0000
673 OFF LABEL USE 31 0.0000
674 ANGINA PECTORIS 1 0.0000
675 LETHARGY 2 0.0000
676 BLOOD CREATINE PHOSPHOKINASE INCREASED 1 0.0000
677 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 1 0.0000
678 ACUTE MYOCARDIAL INFARCTION 1 0.0000
679 PSYCHOTIC DISORDER 1 0.0000
680 WHEEZING 2 0.0000
681 OESOPHAGEAL CARCINOMA 1 0.0000
682 FATIGUE 26 0.0000
683 FEELING HOT 2 0.0000
684 EMOTIONAL DISORDER 1 0.0000
685 BLOOD GLUCOSE INCREASED 6 0.0000
686 RHINORRHOEA 2 0.0000
687 CONFUSIONAL STATE 5 0.0000
688 SWELLING FACE 2 0.0000
689 EYE DISORDER 1 0.0000
690 VIRAL INFECTION 1 0.0000
691 FUNGAL INFECTION 1 0.0000
692 URINARY RETENTION 1 0.0000
693 SOMNOLENCE 6 0.0000
694 MYALGIA 5 0.0000
695 HEPATIC ENZYME INCREASED 2 0.0000
696 HAEMATURIA 1 0.0000
697 ERYTHEMA 6 0.0000
698 CEREBRAL HAEMORRHAGE 1 0.0000
699 PAIN IN EXTREMITY 8 0.0000
700 INJECTION SITE MASS 1 0.0000
701 BRONCHITIS 2 0.0000
702 HYPOAESTHESIA 4 0.0000
703 PLASMA CELL MYELOMA 1 0.0000
704 LUNG NEOPLASM MALIGNANT 1 0.0000
705 TREMOR 4 0.0000
706 OSTEOARTHRITIS 1 0.0000
707 LOSS OF CONSCIOUSNESS 3 0.0000
708 HYPERHIDROSIS 3 0.0000
709 MYOCARDIAL INFARCTION 4 0.0000
710 DEHYDRATION 3 0.0000
711 PULMONARY OEDEMA 1 0.0000
712 GASTROINTESTINAL DISORDER 2 0.0000
713 THERAPEUTIC RESPONSE UNEXPECTED 1 0.0000
714 MEMORY IMPAIRMENT 3 0.0000
715 SKIN IRRITATION 1 0.0000
716 ASTHENIA 8 0.0000
717 RASH ERYTHEMATOUS 1 0.0000
718 CONTUSION 2 0.0000
719 LUNG DISORDER 1 0.0000
720 LEUKOPENIA 1 0.0000
721 AGGRESSION 1 0.0000
722 CELLULITIS 1 0.0000
723 BLOOD PRESSURE INCREASED 3 0.0000
724 SINUSITIS 2 0.0000
725 DYSPNOEA 11 0.0000
726 ABDOMINAL PAIN UPPER 4 0.0000
727 ILLNESS 2 0.0000
728 VOMITING 9 0.0000
729 HAEMORRHAGE 2 0.0000
730 MUSCULOSKELETAL PAIN 1 0.0000
731 DRUG INEFFECTIVE 25 0.0000
732 NAUSEA 15 0.0000
733 HYPERTENSION 4 0.0000
734 INSOMNIA 5 0.0000
735 ANAPHYLACTIC REACTION 1 0.0000
736 BLISTER 1 0.0000
737 BONE PAIN 1 0.0000
738 SURGERY 1 0.0000
739 DIARRHOEA 11 0.0000
740 ARTHRALGIA 7 0.0000
741 CATARACT 1 0.0000
742 IRRITABILITY 1 0.0000
743 STOMATITIS 1 0.0000
744 MUSCLE SPASMS 3 0.0000
745 CHEST PAIN 3 0.0000
746 INTENTIONAL OVERDOSE 1 0.0000
747 DEEP VEIN THROMBOSIS 1 0.0000
748 AMNESIA 1 0.0000
749 PAIN 9 0.0000
750 HEADACHE 9 0.0000
751 BURNING SENSATION 1 0.0000
752 SLEEP DISORDER 1 0.0000
753 ANXIETY 4 0.0000
754 WEIGHT INCREASED 3 0.0000
755 EPISTAXIS 1 0.0000
756 ACNE 1 0.0000
757 DIABETES MELLITUS 1 0.0000
758 INJECTION SITE PAIN 4 0.0000
759 PERIPHERAL SWELLING 2 0.0000
760 ARTHRITIS 1 0.0000
761 PARAESTHESIA 2 0.0000
762 DRUG INTERACTION 2 0.0000
763 FEELING ABNORMAL 3 0.0000
764 PROSTATE CANCER 1 0.0000
765 GASTROOESOPHAGEAL REFLUX DISEASE 1 0.0000
766 DIZZINESS 6 0.0000
767 ABDOMINAL DISCOMFORT 2 0.0000
768 SKIN EXFOLIATION 1 0.0000
769 BALANCE DISORDER 1 0.0000
770 ADVERSE DRUG REACTION 1 0.0000
771 WEIGHT DECREASED 3 0.0000
772 MIGRAINE 1 0.0000
773 DRUG INTOLERANCE 1 0.0000
774 SYNCOPE 1 0.0000
775 FLUSHING 1 0.0000
776 JOINT SWELLING 1 0.0000
777 EMOTIONAL DISTRESS 1 0.0000
778 PRODUCT USE IN UNAPPROVED INDICATION 2 0.0000
779 VISUAL IMPAIRMENT 1 0.0000
780 PRURITUS 3 0.0000
781 CONDITION AGGRAVATED 2 0.0000
782 URTICARIA 1 0.0000
783 CEREBROVASCULAR ACCIDENT 1 0.0000
784 HYPERSENSITIVITY 1 0.0000
785 ALOPECIA 1 0.0000